Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Development of a PPRV challenge model in goats and its use to assess the efficacy of a PPR vaccine.

Enchery F, Hamers C, Kwiatek O, Gaillardet D, Montange C, Brunel H, Goutebroze S, Philippe-Reversat C, Libeau G, Hudelet P, Bataille A.

Vaccine. 2019 Mar 14;37(12):1667-1673. doi: 10.1016/j.vaccine.2019.01.057. Epub 2019 Feb 13.

2.

Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.

Breard E, Belbis G, Viarouge C, Nomikou K, Haegeman A, De Clercq K, Hudelet P, Hamers C, Moreau F, Lilin T, Durand B, Mertens P, Vitour D, Sailleau C, Zientara S.

Vaccine. 2015 Jan 15;33(4):512-8. doi: 10.1016/j.vaccine.2014.11.053. Epub 2014 Dec 11.

PMID:
25500308
3.

A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.

Nunes SF, Hamers C, Ratinier M, Shaw A, Brunet S, Hudelet P, Palmarini M.

J Virol. 2014 Nov;88(21):12222-32. doi: 10.1128/JVI.02183-14. Epub 2014 Aug 20.

4.

Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes.

Leemans J, Hamers C, Chery R, Bibard A, Besancon L, Duboeuf M, Hudelet P, Goutebroze S, Kirschvink N.

Vaccine. 2013 Apr 8;31(15):1975-80. doi: 10.1016/j.vaccine.2013.02.005. Epub 2013 Feb 17.

PMID:
23422141
5.

Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.

Shaw AE, Ratinier M, Nunes SF, Nomikou K, Caporale M, Golder M, Allan K, Hamers C, Hudelet P, Zientara S, Breard E, Mertens P, Palmarini M.

J Virol. 2013 Jan;87(1):543-57. doi: 10.1128/JVI.02266-12. Epub 2012 Oct 24.

6.

Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.

Bréard E, Belbis G, Hamers C, Moulin V, Lilin T, Moreau F, Millemann Y, Montange C, Sailleau C, Durand B, Desprat A, Viarouge C, Hoffmann B, de Smit H, Goutebroze S, Hudelet P, Zientara S.

Vaccine. 2011 Mar 16;29(13):2495-502. doi: 10.1016/j.vaccine.2010.12.105. Epub 2011 Jan 21.

PMID:
21256877
7.

Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.

Hamers C, Galleau S, Chery R, Blanchet M, Besancon L, Cariou C, Werle-Lapostolle B, Hudelet P, Goutebroze S.

Vet Rec. 2009 Sep 26;165(13):369-73.

PMID:
19783850
8.

Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.

Hamers C, Rehbein S, Hudelet P, Blanchet M, Lapostolle B, Cariou C, Duboeuf M, Goutebroze S.

Vaccine. 2009 May 11;27(21):2789-93. doi: 10.1016/j.vaccine.2009.02.099. Epub 2009 Mar 10.

PMID:
19366576
9.

Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.

Savini G, Hamers C, Conte A, Migliaccio P, Bonfini B, Teodori L, Di Ventura M, Hudelet P, Schumacher C, Caporale V.

Vet Microbiol. 2009 Jan 1;133(1-2):1-8. doi: 10.1016/j.vetmic.2008.05.032. Epub 2008 Jun 8.

PMID:
18617335
10.

Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.

Couvreur B, Letellier C, Olivier F, Dehan P, Elouahabi A, Vandenbranden M, Ruysschaert JM, Hamers C, Pastoret PP, Kerkhofs P.

Vet Res. 2007 Nov-Dec;38(6):819-34. Epub 2007 Aug 31.

11.
12.

Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.

Dehan P, Couvreur B, Hamers C, Lewalle P, Thiry E, Kerkhofs P, Pastoret PP.

Vaccine. 2005 Jul 21;23(33):4236-46.

PMID:
16005739
13.

Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge.

Hamers C, Couvreur B, Dehan P, Letellier C, Fischer L, Brun AJ, Lewalle P, Michaux C, Pastoret PP, Kerkhofs P.

Vet Rec. 2003 Aug 23;153(8):236-40.

PMID:
13677324
14.

Genetic and antigenic variability in bovine viral diarrhea virus (BVDV) isolates from Belgium.

Couvreur B, Letellier C, Collard A, Quenon P, Dehan P, Hamers C, Pastoret PP, Kerkhofs P.

Virus Res. 2002 Apr 23;85(1):17-28.

PMID:
11955635
15.

Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.

Hamers C, Di Valentin E, Lecomte C, Lambot M, Joris E, Genicot B, Pastoret PP.

Vet J. 2002 Jan;163(1):61-7.

PMID:
11749137
16.

Diversity among bovine pestiviruses.

Hamers C, Dehan P, Couvreur B, Letellier C, Kerkhofs P, Pastoret PP.

Vet J. 2001 Mar;161(2):112-22. Review.

PMID:
11243683
17.

Virus neutralizing antibodies against a panel of 18 BVDV isolates in calves vaccinated with Rispoval RS-BVD.

Hamers C, di Valentin E, Lecomte C, Lambot M, Joris E, Genicot B, Pastoret PP.

J Vet Med B Infect Dis Vet Public Health. 2000 Dec;47(10):721-6.

PMID:
11204126
18.

Differences in experimental virulence of bovine viral diarrhoea viral strains isolated from haemorrhagic syndromes.

Hamers C, Couvreur B, Dehan P, Letellier C, Lewalle P, Pastoret PP, Kerkhofs P.

Vet J. 2000 Nov;160(3):250-8.

PMID:
11061962
19.

Antigenic diversity of bovine viral diarrhoea viral isolates contradicts the concept of herd specific strain.

Hamers C, Lambot M, Onclin M, Lecomte C, Pastoret PP.

Epidemiol Infect. 1998 Oct;121(2):451-7.

20.

Bovine viral diarrhoea virus induces apoptosis in blood mononuclear cells by a mechanism largely dependent on monocytes.

Lambot M, Hanon E, Lecomte C, Hamers C, Letesson JJ, Pastoret PP.

J Gen Virol. 1998 Jul;79 ( Pt 7):1745-9.

PMID:
9680138
21.

Persistently infected cattle stabilise bovine viral diarrhea virus leading to herd specific strains.

Hamers C, Lecomte C, Kulcsar G, Lambot M, Pastoret PP.

Vet Microbiol. 1998 Mar 31;61(3):177-82.

PMID:
9631529
22.

A Molecular Chameleon: Chromophoric Sensing by a Self-Complexing Molecular Assembly.

Wolf R, Asakawa M, Ashton PR, Gómez-López M, Hamers C, Menzer S, Parsons IW, Spencer N, Stoddart JF, Tolley MS, Williams DJ.

Angew Chem Int Ed Engl. 1998 Apr 20;37(7):975-979. doi: 10.1002/(SICI)1521-3773(19980420)37:7<975::AID-ANIE975>3.0.CO;2-L.

PMID:
29711472
23.

A Chemically and Electrochemically Switchable [2]Catenane Incorporating a Tetrathiafulvalene Unit.

Asakawa M, Ashton PR, Balzani V, Credi A, Hamers C, Mattersteig G, Montalti M, Shipway AN, Spencer N, Stoddart JF, Tolley MS, Venturi M, White AJP, Williams DJ.

Angew Chem Int Ed Engl. 1998 Feb 16;37(3):333-337. doi: 10.1002/(SICI)1521-3773(19980216)37:3<333::AID-ANIE333>3.0.CO;2-P.

PMID:
29711270
24.

[Interspecies transmissibility of spongiform encephalopathies].

Pastoret PP, Hamers C, Brochier B.

Rev Med Liege. 1996 Nov;51(11):705-13. Review. Multiple languages. No abstract available.

PMID:
9011924
25.

Naturally occurring antibodies devoid of light chains.

Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R.

Nature. 1993 Jun 3;363(6428):446-8.

PMID:
8502296

Supplemental Content

Loading ...
Support Center